Skip to Content
Exit Menu

Membership and affiliation

Invited speaker

  • “How can genetic studies inform us about the role of adiposity in metabolic and non-metabolic disease outcomes”, LUDC virtual seminar, Lund, Sweden, 14th January 2021.
  • “Genetics of favourable adiposity may contribute to excess risk of diabetes in non-Europeans”, The 10th Aslla Symposium, Gangneung, South Korea, 9th-11th December 2019.
  • “Favourable adiposity genes pinpoint to the role of subcutaneous and liver fat in the ethnic differences in adiposity and diabetes risk”, Berzelius Symposium: Obesity and Type 2 Diabetes, Umea, Sweden, 11th September 2019.
  • “Using genetics to understand the consequences of higher adiposity uncoupled from its adverse metabolic effects”, 4th International Mendelian randomization conference, Bristol, UK, 17th-19th July 2019.
  • “The genetics of “favourable adiposity” and ethnic differences in adiposity and diabetes risk”, Servier-IGIS meeting, Nice, France, 29th March 2019.
  • “Combining UK Biobank genetics and MRI imaging data to identify genetic factors associated with higher body fat % but lower risk of diabetes.”, UK Biobank conference, London, UK, 21st June 2018.
  • “Identification of alleles associated with higher body fat percentage but lower risk of type 2 diabetes”, European Association for the study of Diabetes conference, 11-15 September 2017, Lisbon, Portugal.
  • “How can genetic studies inform us about the role of obesity in insulin resistance”, The 12th International Congress on Obesity, 17-20 March 2014, Kuala Lumpur, Malaysia.
  • “The genetics of “favourable adiposity” and ethnic differences in adiposity and diabetes risk”, Diabetes UK conference, Liverpool, UK, 6th-9th March 2019.
  • “Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration”, ESHG conference, Gothenburg, Sweden, 15th-18th June 2019.
  • “Carrying more “favourable adiposity” genetic factors is associated with higher adiposity but lower ectopic fat and lower risk of type 2 diabetes.”, Diabetes UK, 14-16 March 2018, London, UK.
  • “Uncoupling “healthy obesity” from “unhealthy obesity” genetic variants to provide a tool for Mendelian randomization studies”, Mendelian Randomization conference, 11-13 July 2017, Bristol, UK.
  • "Novel loci associated with birth weight provide biological links between intrauterine growth, postnatal growth and metabolic traits", Diabetes UK Professional Conference 2012, 7–9 March 2012, Glasgow, UK.